Quick Overview: In the past 18 months, Tarveda Therapeutics has been refocusing its efforts on Pentarins, its miniaturized drug conjugates, ... An increased focus on the need to access and develop truly transformational medicines was a key theme in the hallway chatter at ... We are seeing rapid progress in biomedicine, from inexpensive whole genome sequencing, to Big Data analytics, ...
Pharmabcine Presentation At Biotech Showcase - Detailed Overview & Context
In the past 18 months, Tarveda Therapeutics has been refocusing its efforts on Pentarins, its miniaturized drug conjugates, ... An increased focus on the need to access and develop truly transformational medicines was a key theme in the hallway chatter at ... We are seeing rapid progress in biomedicine, from inexpensive whole genome sequencing, to Big Data analytics, ... It's no secret that the life sciences industry has had some challenging moments with lawmakers in recent years. And despite efforts ... Chief Strategy Officer and Head of Drug Discovery, Stacie Calad-Thomson, Ph.D., provides an overview of BioSymetrics at the ... CEO of TeraImmune, Yongchan, Ph.D., presents the company's substantial progress of lead program TI-168(Hemophilia A) and ...
Minovia Therapeutics co-Founder and CEO, Natalie Yivgi-Ohana
![PharmAbcine Presentation at Biotech Showcase 2022 [Eng/Kor Sub]](https://i.ytimg.com/vi/9VTaJwnVyPI/mqdefault.jpg)
![PharmAbcine Presentation at BIO Europe 2021 [Eng/Kor Sub]](https://i.ytimg.com/vi/q_YEEuqgcuc/mqdefault.jpg)
![PharmAbcine at Access China Biotech Forum Winter Showcase 2022 [Eng/Kor Sub]](https://i.ytimg.com/vi/3OhnsTqyULU/mqdefault.jpg)
![PharmAbcine Presentation at Access China Biotech Forum 2021 [Eng/Kor Sub]](https://i.ytimg.com/vi/Uemqg0B9OXs/mqdefault.jpg)
